What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Inflammation
Pål Aukrust spends much of his time researching Internal medicine, Immunology, Endocrinology, Heart failure and Inflammation.
The study incorporates disciplines such as Gastroenterology and Cardiology in addition to Internal medicine.
His study in Cytokine, Tumor necrosis factor alpha, Interleukin, Chemokine and Monocyte are all subfields of Immunology.
His Endocrinology research is multidisciplinary, relying on both Receptor, Nonalcoholic fatty liver disease, T cell and Receptor antagonist.
The various areas that Pål Aukrust examines in his Heart failure study include Heart disease, Rosuvastatin and Hazard ratio.
His study in Inflammation is interdisciplinary in nature, drawing from both Lesion, Pathogenesis, Platelet activation, Platelet and Vascular disease.
His most cited work include:
- Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes (496 citations)
- Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (425 citations)
- Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 (418 citations)
What are the main themes of his work throughout his whole career to date?
Pål Aukrust mainly investigates Internal medicine, Immunology, Inflammation, Endocrinology and Cardiology.
His research links Gastroenterology with Internal medicine.
Much of his study explores Immunology relationship to Peripheral blood mononuclear cell.
His studies in Inflammation integrate themes in fields like Platelet activation, Receptor and Pathogenesis, Pathology.
His Endocrinology research is multidisciplinary, incorporating perspectives in Inflammasome and Osteoprotegerin.
His Cardiology study combines topics from a wide range of disciplines, such as Surgery and Hazard ratio.
He most often published in these fields:
- Internal medicine (77.79%)
- Immunology (40.14%)
- Inflammation (35.51%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (77.79%)
- Inflammation (35.51%)
- Immunology (40.14%)
In recent papers he was focusing on the following fields of study:
Pål Aukrust mostly deals with Internal medicine, Inflammation, Immunology, Endocrinology and Cardiology.
His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology.
His Inflammation study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Lipoprotein, Transplantation and Monocyte.
His studies deal with areas such as Peripheral blood mononuclear cell and Disease as well as Immunology.
Insulin resistance is closely connected to Inflammasome in his research, which is encompassed under the umbrella topic of Endocrinology.
As part of one scientific family, he deals mainly with the area of Cardiology, narrowing it down to issues related to the Randomized controlled trial, and often Rosuvastatin.
Between 2017 and 2021, his most popular works were:
- Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. (408 citations)
- Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint) (121 citations)
- Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
Internal medicine, Immunology, Inflammation, Myocardial infarction and Cardiology are his primary areas of study.
Pål Aukrust interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
As a part of the same scientific study, he usually deals with the Immunology, concentrating on Odds ratio and frequently concerns with Respiratory system, Case-control study, Complement system, Lectin pathway and Coronavirus.
The Inflammation study combines topics in areas such as COPD, Lung cancer, FOXP3 and Innate immune system.
His biological study spans a wide range of topics, including Coronary artery disease and Tocilizumab, Disease.
The concepts of his Cardiology study are interwoven with issues in Endurance training, Physical exercise and C-reactive protein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
